VELOCITY-Lung: A phase (Ph) 2 study evaluating safety and efficacy of domvanalimab (dom) + zimberelimab (zim) + sacituzumab govitecan (SG), or etrumadenant (etruma) + dom + zim, or etruma + zim in patients (pts) with treatment-naïve metastatic...
| Autor: | Spira, Alexander I., Chiu, Joanne, Wang, Chin Chou, Zer, Alona, Conibear, John, Phuong, Patrick Hoang, Park, Joseph K., Seto, Anna, Zhang, Jie, Cho, Byoung Chul |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pTPS9155-TPS9155, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|